Anubrato Aich

Anubrato Aich has a diverse work experience in the field of scientific research and development. Anubrato began their career in 2013 as an intern at Biocon, where they gained valuable experience in the industry. Anubrato then joined the same company as a Scientist in 2014, where they worked on various projects and contributed to the development of innovative products. In 2016, they were promoted to the role of Senior Scientist at Biocon, where they continued to excel and contribute to the company's success. In 2018, Anubrato joined Novo Nordisk as a Scientist, focusing on downstream process design and development of E. Coli expressed proteins, targeting the fields of diabetes and obesity. Anubrato'scontributions in this role were highly valued. Later in 2018, they transitioned to AmbioPharm as a Scientist - Project Lead, where they continue to utilize their expertise and leadership skills in managing projects. Anubrato's experience and expertise in scientific research and development make him a valuable asset to any organization in need of innovative solutions.

Between 2007 and 2011, Anubrato Aich attended Vellore Institute of Technology, although the specific field of study is unknown. Then, in 2011, they enrolled in the University of Warwick and studied Biotechnology and Bioprocess for the duration of one year before completing their education at the institution in 2012.